Needle vs. scalpel: which dialysis access works best?
NCT ID NCT05654103
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 4 times
Summary
This study compares two methods for creating an arteriovenous fistula (AVF) in people with end-stage kidney disease who need dialysis. The newer endovascular method uses a needle through the skin, while the traditional surgical method requires an incision. Researchers will enroll 90 patients who qualify for both procedures and randomly assign them to one method, tracking how well the fistula matures and how long it lasts. The goal is to gather data for a larger study to determine which approach is better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- endoAVF device and surgical AVF procedure
- What this could lead to
- If this trial succeeds, it could show that the newer needle-based method for creating dialysis access is as good as or better than surgery, potentially offering a less invasive option for kidney patients.
- What could go wrong
- This is a small pilot study with only 90 participants, so results may not apply to everyone. The newer method may require more follow-up procedures, and it's too early to know which approach is truly better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE ON DIALYSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCLA Division of Vascular and Endovascular Surgery Clinic
Los Angeles, California, 90095, United States
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15231, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new graft keep dialysis access working longer?
- Could a Starch-Based drug clean toxins from dialysis Patients' blood?
- Can a diabetes drug boost dialysis efficiency for kidney patients?
- New study peers inside lungs during Clot-Busting procedure
- New pill could help dialysis patients control dangerous phosphate levels
- Tiny study tests diuretics for dialysis patients – terminated early